Eli Lil­ly, UCB and oth­ers Switch in­to gear with $52M for new RNA biotech

South San Fran­cis­co biotech Switch Ther­a­peu­tics un­wrapped Tues­day morn­ing with $52 mil­lion to fi­nance con­di­tion­al­ly ac­ti­vat­ed siR­NA mol­e­cules.

As its name sug­gests, the start­up said …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER